Inventor · disambiguated record
Michael J. Gerber
Also filed as: GERBER MICHAEL · GERBER MICHAEL J
21 granted patents·15 pending applications·385 citations·filing 1994–2022
96Inventor score
Files withGILEAD COLORADO INC5GILEAD SCIENCES INC5ABBVIE DEUTSCHLAND4GERBER MICHAEL J3GILEAD CALISTOGA LLC3
Top patents by PatentIndex Score
36 records- 0194US8865730B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2013·Granted Oct 21, 2014·25 cites·12 claims
- 0288US9469643B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Oct 18, 2016·9 cites·6 claims
- 0387US8865650B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 21, 2014·9 cites·32 claims
- 0487US8377933B2Method for treating a pulmonary hypertension conditionGILEAD COLORADO INC·Filed 2011·Granted Feb 19, 2013·13 cites·11 claims
- 0586US5677330AMedical uses of allosteric hemoglobin modifier compounds in patient careINNOVATIVE TECH CENTER·Filed 1995·Granted Oct 14, 1997·73 cites·14 claims
- 0686US5631219AMethod of stimulating hematopoiesis with hemoglobinSOMATOGEN INC·Filed 1994·Granted May 20, 1997·91 cites·24 claims
- 0784US10730879B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 4, 2020·2 cites·4 claims
- 0884US9592231B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 14, 2017·6 cites·16 claims
- 0984US8623819B2Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2013·Granted Jan 7, 2014·6 cites·15 claims
- 1081US9504685B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·2 cites·6 claims
- 1178US9474752B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2014·Granted Oct 25, 2016·2 cites·15 claims
- 1278US5927283AAllosteric modifiers of hemoglobinUNIV VIRGINIA COMMONWEALTH·Filed 1997·Granted Jul 27, 1999·47 cites·2 claims
- 1375US6214879B1Allosteric inhibitors of pyruvate kinaseUNIV VIRGINIA COMMONWEALTH·Filed 1998·Granted Apr 10, 2001·44 cites·3 claims
- 1474US8470295B2Methods of treatment of androgenic steroidal hormone dependent cancer with auger electron-emitting nucleoside analogsWARREN STEPHEN L·Filed 2008·Granted Jun 25, 2013·5 cites·22 claims
- 1566US8600479B2Guidance and implantation of cathetersDALKE WILLIAM D·Filed 2008·Granted Dec 3, 2013·7 cites·59 claims
- 1664US9993475B2Method for treating a pulmonary hypertension conditionGILEAD SCIENCES INC·Filed 2016·Granted Jun 12, 2018·0 cites·6 claims
- 1763US2008139593A1Method for treating a pulmonary hypertension conditionGERBER MICHAEL J·Filed 2007·Application pending·0 cites
- 1862US2025320250A1Pharmaceutical compositions for the treatment of visceral painIRONWOOD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1959US2009054473A1Therapy for complications of diabetesGILEAD COLORADO INC·Filed 2008·Application pending·0 cites
- 2057US2013116257A1Method for treating a pulmonary hypertension conditionGILEAD COLORADO INC·Filed 2012·Application pending·0 cites
- 2155US5914391AStabilized compositions containing hemoglobinBAXTER BIOTECH TECH SARL·Filed 1995·Granted Jun 22, 1999·9 cites·33 claims
- 2255US5827888APerinatal treatment of a fetus to avoid oxygen deprivationINNOVATIVE TECH CENTER·Filed 1996·Granted Oct 27, 1998·15 cites·1 claims
- 2355US2017079978A1Therapy for complications of diabetesABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 2453US2008145433A1Darusentan oral dosage formGILEAD COLORADO INC·Filed 2007·Application pending·0 cites
- 2553US2010152217A1Method for treating a pulmonary hypertension conditionGERBER MICHAEL J·Filed 2010·Application pending·0 cites
- 2652US6242417B1Stabilized compositions containing hemoglobinSOMATOGEN INC·Filed 1995·Granted Jun 5, 2001·7 cites·18 claims
- 2751US2009221549A1Antihypertensive therapyGILEAD COLORADO INC·Filed 2007·Application pending·0 cites
- 2850US2015037410A1Pharmaceutical compositions of ranolazine and dronedaroneGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 2948US5750132ATreatment of adverse effects associated with administration of extracellular hemoglobinSOMATOGEN INC·Filed 1995·Granted May 12, 1998·10 cites·14 claims
- 3044US7097825B2Methods and reagents to acquire MRI signals and imagesALLOS THERAPEUTICS INC·Filed 2002·Granted Aug 29, 2006·3 cites·11 claims
- 3142US2016213569A1Pharmaceutical compositions of ranolazine and dronedaroneGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3242US2011135569A1Method for therapeutic administration of radionucleosidesPEAK BIOSCIENCES INC·Filed 2008·Application pending·0 cites
- 3341US2006025463A1Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseasesBRISTOW MICHAEL·Filed 2005·Application pending·0 cites
- 3441US2007196510A1Method for treating resistant hypertensionGERBER MICHAEL J·Filed 2006·Application pending·0 cites
- 3535US2006292213A1Enoximone formulations and their use in the treatment of PDE-III mediated diseasesMYOGEN INC·Filed 2005·Application pending·0 cites
- 3635US2006030611A1Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseasesMYOGEN INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael J. Gerber files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →